MS patients are being ‘denied’ access to NHS Sativex Says Media Report

CANNANNEW REPORT reports The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. In 2018 the UK Government relaxed the laws and allowed cannabis and cannabis based medicinal products (CBMP) to be prescribed by specially trained doctors, yet many thousands of people are complaining that they are effectively being ‘denied’ access to it. The charity said that multiple sclerosis – which affects the brain and the spinal cord, and causes a wide array of symptoms –  is the only medical condition that has a licensed cannabis-based treatment, specifically for spasticity, but patients have been unable to access it on the NHS despite the National Institute for Health and Care Excellence (NICE) approving its use nearly three years ago. “Eligible people with MS are being denied the option to try it,” the authors of the report wrote. “Many are finding that despite the treatment being approved, they are being denied access in their area.” The charity found that out of 106 clinical commissioning groups in England, only 49 were routinely offering cannabis based treatment. It’s estimated that 4800 people would be eligible for cannabis based treatment, but just 630 are being offered it. “This means that thousands of people with MS could be missing out on a treatment that’s safe, effective and could greatly improve their quality of life,” the authors said. The charity also said that patients who desperately need this treatment are being forced into using the black market, which can be problematic for patients, or going to a private clinic that can be prohibitively expensive. Chris Todd was diagnosed with MS in 1999, he lives in Hull with his wife Anne who also suffers from relapsing MS. Chris has severe spasticity, suffers from fatigue and other…

Excerpt only …
Source : MS patients are being ‘denied’ access to NHS Sativex Says Media Report

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.